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Introduction
Congenital Heart Disease is the most prevalent of  all clinically relevant human birth defects, affecting 
approximately 1% of  children (1). Much higher rates are actually scored if  milder clinically silent defects in 
childhood are accounted for, including bicuspid aortic valve, aneurism of  the atrial septum, and persistent 
left superior vena cava (2). Advances in prenatal diagnosis, improved surgical procedures, and aftercare in 
modern medicine have led to a continual increase in survival rates of  patients bearing congenital cardiac 
malformations. More recent data places the number of  adults presenting some form of  congenital heart 
disease worldwide at approximately 21 million (3). Congenital heart disease survivors have significant 
improvements in quality of  life, reach adulthood, and start new families, and as a consequence, modern 
society is experiencing an annual increase in the proportion of  genetically predisposed individuals who can 
develop cumulative and severe cardiac dysfunctions (4).
The homeobox transcription factor Nkx2-5 is recognized as one of  the pivotal genes associated with 
heart defects (5). Nkx2-5 expression is highly evolutionarily conserved and is essential for heart development 
Mutations in the Nkx2-5 gene are a main cause of congenital heart disease. Several studies have 
addressed the phenotypic consequences of disrupting the Nkx2-5 gene locus, although animal 
models to date failed to recapitulate the full spectrum of the human disease. Here, we describe 
a new Nkx2-5 point mutation murine model, akin to its human counterpart disease–generating 
mutation. Our model fully reproduces the morphological and physiological clinical presentations 
of the disease and reveals an understudied aspect of Nkx2-5–driven pathology, a primary right 
ventricular dysfunction. We further describe the molecular consequences of disrupting the 
transcriptional network regulated by Nkx2-5 in the heart and show that Nkx2-5–dependent 
perturbation of the Wnt signaling pathway promotes heart dysfunction through alteration of 
cardiomyocyte metabolism. Our data provide mechanistic insights on how Nkx2-5 regulates heart 
function and metabolism, a link in the study of congenital heart disease, and confirms that our 
models are the first murine genetic models to our knowledge to present all spectra of clinically 
relevant adult congenital heart disease phenotypes generated by NKX2-5 mutations in patients.
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and determination of  myocardial cell fate (6). Absence of  Nkx2-5 in mice results in impaired cardiac 
growth and chamber formation, deranged gene regulatory networks, and early embryonic lethality (7, 
8). Deletion at postnatal stages has shown that Nkx2-5 activity is essential for maintenance of  the cardi-
ac conduction system (9–12). Overexpression of  Nkx2-5 also underpins conduction defects in myotonic 
dystrophy in a mouse model (13).
Mutations in the NKX2-5 human gene have an incidence of  ~4% of  all congenital heart diseases in 
patients (5), being one of  the most common genetic causes of  congenital heart disease, and are associated 
with severe structural and functional cardiac impairment. More than 50 NKX2-5 mutations have been asso-
ciated with a diverse range of  heart muscle, septal, and conduction system defects (14–20). Patients with 
a wide range of  heterozygous NKX2-5 mutations display diverse cardiac abnormalities that include septal 
defects, conotruncal malformations, hypoplastic left heart, dilated cardiomyopathy, and atrioventricular 
conduction block (5). Long-term followup of  patients carrying NKX2-5 mutations show 94% prevalence 
of  atrioventricular block with increased atrial fibrillation episodes and high incidence of  sudden death, 
highlighting the importance of  this gene in adult life and long-term followup, especially given the aging 
cohort of  patients carrying congenital heart disease (21). We have recently uncovered a NKX2-5 mutation 
in a family that showed septal malformations, left ventricular noncompaction, dilated cardiomyopathy, and 
conduction defects over 3 generations (22). This mutation creates an isoleucine to methionine (I-M) change 
at position 184 of  the protein homeodomain region, critical for NKX2-5 function. This mutation is equiv-
alent to position 183 in mice. Mutations in this residue were also recently found in two new independent 
families that share most landmarks seen in our original findings. These landmarks included the presence of  
dilated cardiomyopathy, normally not seen in other families harboring NKX2-5 mutations (23). Biochem-
ical characterization of  this protein showed that mutations in this residue lead to decreased binding and 
transcriptional activity (22).
Most current data regarding NKX2-5 dysfunction in disease were obtained using mouse models con-
taining partial/full deletion or overexpression of  mutated Nkx2-5 (9–13, 24). These models have been 
proven too severe or only displayed partial penetrance of  the spectrum of  phenotypic changes observed in 
patients, providing only marginal insights into the mechanisms of  action of  Nkx2-5 in disease generation. 
Specifically, such models did not reproduce the human condition because it is likely caused by partial dis-
ruption of  protein function (22, 25).
Here, we describe a Nkx2-5 knockin mouse model that faithfully reproduces most of  the characteristics 
of  NKX2-5 mutations in patients and uncovers an important and unexplored link between Nkx2-5 regula-
tion of  the Wnt signaling pathway and late-onset adult congenital heart disease.
Results
NKX2-5 I-M and I-P mutant proteins display decreased affinity for native DNA binding sites. We have previously 
reported a novel familial I-M mutation at the highly conserved position 184 of  the homeodomain region of  
the NKX2-5 protein. Affected members of  this family displayed most of  the classical clinical characteristics 
described for NKX2-5 gene disruption (22). The mutation showed complete correlation with development 
of  the phenotype, including a previously undetected ventricular dilation. Biochemical characterization of  
the I-M mutant protein showed decreased DNA binding affinity and partial transcriptional impairment. In 
contrast, mutation of  the same residue to a proline (I-P) led to a much more severe functional impairment 
of  protein activity in vitro (22). This latter change has been previously used to test the effect of  the over-
expression of  a “dominant negative” form of  Nkx2-5 in mice, causing ventricular dilation and mortality 
associated with severe arrhythmic episodes (26).
Although important when defining the biochemical properties of  mutant proteins, in vitro assays (22, 
25, 27) are somewhat limited in spectrum, as changes in binding affinity and/or transcriptional activity 
are only tested in selected targets and cannot address the overall changes observed in native DNA sites. To 
overcome this issue, we analyzed the kinetics of  murine I-M and I-P NKX2-5 mutant proteins using multi-
photon-based photoactivation and fluorescence correlation spectroscopy (28) (Figure 1).
While photoactive GFP (paGFP) shows free diffusion, interpreted as no DNA binding (Figure 1B and 
Supplemental Table 1; supplemental material available online with this article; https://doi.org/10.1172/
jci.insight.88271DS1), NKX2-5 WT protein shows anomalous slow diffusion parameter, indicative of  pro-
tein-DNA binding in the HL-1 nucleus. Dwell time of  the slow diffusion component for NKX2-5 WT 
was 108.1 ± 9.98. NKX2-5 I183M-paGFP protein displayed reduced dwell time (65.21 ± 6.71), reflecting 
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decreased DNA binding to endogenous genome targets. NKX2-5 I183P-paGFP had even lower dwell time 
(34.03 ± 3.06), consistent with a more severe impairment of  the DNA binding domain by the I-P change 
and predicted structural changes in the homeodomain region (22). These experiments confirm that the 
mutant proteins display a significant reduction in DNA binding affinity to endogenous sites in situ and 
therefore must lead to a wide array of  changes in transcription regulatory networks in vivo, corroborating 
our biochemical observations for patients with familial congenital heart disease (22).
Homozygous Nkx2-5 point mutations are embryonic lethal and phenocopy-null models. As previously men-
tioned, current disease murine models for Nkx2-5 do not fully reproduce the human condition; there-
fore, proper models to study the mechanisms associated with the development of  cardiac dysfunction 
are needed. To analyze the transcriptional activity and consequent phenotype of  NKX2-5 mutant 
proteins in vivo, we engineered point mutations at the I183 residue (equivalent to I184 in humans), 
replacing it with either the original isoleucine sequence (Nkx2-5 control), I to M (c-g) or I to P (atc-
cca) that lead to methionine or proline residue changes at 183 position (Figure 2A and Supplemental 
Figure 1). Genomic targeting was confirmed by Southern blot and sequencing of  recombineered mice 
(Figure 2B and Supplemental Figure 1).
To determine the relative strength of  the M and P mutations, Nkx2-5183M/+ or Nkx2-5183P/+ heterozygous 
mice were intercrossed for Mendelian birth ratio analysis. Nkx2-5 null mice (Nkx2-5Δ/Δ) die around 10.5 days 
after coitum in embryonic development (7, 8, 29). No homozygous Nkx2-5183M/183M or Nkx2-5183P/183P offspring 
were obtained, while mice in the control line Nkx2-5C/C were born with expected ratios (Supplemental Table 
2). In developmental analyses, no mutant Nkx2-5183M/183M or Nkx2-5183P/183P embryos were found past 11.5 
days after coitum. At 10.5 days after coitum, embryos displayed severe growth retardation and heart abnor-
malities (Figure 3A), whereas embryos were viable at 9.5 days after coitum but displayed dysmorphic 
hearts arrested at the looping stage. This phenotype was more pronounced in Nkx2-5183P/183P when compared 
with Nkx2-5183M/183M embryos. No defects were observed in heterozygous embryos.
Expression levels of  Nppa (a direct target of  NKX2-5) were downregulated in the outer curvature of  
the heart in Nkx2-5183M/183M embryos at 9.5 days after coitum, while a residual expression in the atrial-form-
ing regions was seen (Figure 3B). Consistent with the more severe phenotype observed in Nkx2-5183P/183P 
embryos, no significant expression of  Nppa was detected (Figure 3B). Mlc2v (a marker of  the developing 
myocardium) was still present in both mutants, indicating that the initial steps of  cardiac specification were 
intact, although subsequent cardiac morphogenesis, maturation, and function were arrested. Heterozygous 
Nkx2-5183M/+ and Nkx2-5183P/+ embryos showed normal Nppa and Mlc2v expression when compared with the 
WT littermates (Figure 3C). Our data highlight the severity of  these homeodomain point mutations, which 
Figure 1. NKX2-5 mutant protein displays decreased affinity for its endogenous DNA binding sites. In situ analysis 
of DNA binding in transiently transfected HL-1 cardiomyocytes confirms decreased affinity of Nkx2-5 I184M and P 
for target sites. (A) Example of nucleus analyzed by photoactivation; H2B-RFP fluorescence (red) colocalizes with 
Nk2-5-paGFP–transcfected (green) cells, while GFP can only be visualized after photoactivation. (B) Typical autocor-
relation curves for paGFP and NKX2-5 proteins (WT, 183M, and 183P), showing fast and slow diffusion components 
for each protein. Note anomalous diffusion for NKX2-5 mutant proteins. pa, photoactivatable; RFP, red fluorescent 
protein; G, fluctuations in fluorescence; τ, time in milliseconds.
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are as disruptive for normal heart development as the total lack of  NKX2-5 protein and explain why only 
heterozygous mutations in the NKX2-5 gene are seen in patients (30).
Nkx2-5 heterozygous mutants develop adult-onset cardiac dysfunction. Although heterozygous mice carrying 
Nkx2-5 M or P mutations were viable and fertile, a small decrease in the prevalence of  mutant Nkx2-5183M/+ or 
Nkx2-5183P/+ when compared with Nkx2-5C/+ mice was observed, although not statistically significant (Supple-
mental Table 2). No differences in mortality rates after birth were found. Nevertheless, morphological analy-
sis of  adult hearts showed the presence of  highly penetrant heart pathology in both mutant lines (Figure 4A 
and Supplemental Figure 2), presented as right ventricle and right atrial dilation and misalignment in rela-
tion to the left ventricle. Furthermore, Nkx2-5183P/+ mice also displayed increased trabecular layers on the left 
ventricular wall, indicative of  left ventricular noncompaction, commonly observed in patients with NKX2-5 
mutations and also found in our patient cohort (22) (Figure 4B and Supplemental Videos 1–3). Functional 
analysis of  hearts showed a highly significant right ventricular dysfunction in both mutant lines, associat-
ed with a significant decrease in right ventricle ejection fraction (Figure 4C and Supplemental Table 3). 
By contrast, left ventricular function was only affected in Nkx2-5183M/+ mice, which showed decreased end 
diastolic volume (LV-EDV) and stroke volume (LV-SV) and heart mass (LV-mass) (Supplemental Table 3). 
The right ventricular dysfunction could be either a primary defect of  the muscle or secondary to hemody-
namic changes associated with the pulmonary circulation, as Nkx2-5 is important for proper outflow tract 
formation during embryonic development (31, 32). To address whether right ventricular dysfunction in our 
mutants is due to changes in the pulmonary circulation, we analyzed pulmonary and aortic artery diameters 
using microCT in embryos 18.5-day after coitum, when the pulmonary circulation is still not functional. 
Nkx2-5183P/+ embryos showed a significant increase in pulmonary artery diameter when compared with WT 
littermates (Supplemental Figure 3). In contrast, no changes in aorta diameter were observed (Supplemental 
Figure 3). Pulmonary artery enlargement would likely decrease pulmonary afterload and should not con-
tribute to the right ventricular dilation, thus demonstrating that the defects seen in Nkx2-5 mutants are likely 
Figure 2. Targeting constructs and strategy for generation of Nkx2-5 mouse knock-in model. (A) Diagram showing Nkx2-5 conditional mouse con-
struct. (B) Southern blot analysis of targeted embryonic stem cells showing recombination using 5′ and 3′ probes. Nc, NcoI; P, PvuII; X, XbaI; N, NotI; 
Xh, XhoI; M, MluI; Bg, BglII; E, EchoRI; 5′P, 5′Southern probe; 3′P, 3′ Southern probe; LoxP, Cre-recombinase cleavage sites; PGK-Neo, phosphoglycerate 
kinase promoter, neomycin resistance gene.
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primary to intrinsic muscle dysfunction. Together, these data indicate that mutations in the murine Nkx2-5 
gene cause severe right ventricular dysfunction in young adult animals, while compensatory mechanisms are 
most likely at place to ensure proper left ventricular function.
Presence of  atrial septal defects in Nkx2-5 heterozygous mutant mice. One of  the consistently observed 
phenotypes in patients with mutations in NKX2-5 is the presence of  septal defects, accounting for 
8%–19% of  all detected familial atrial septal defects (16, 33, 34). Atrial septum formation requires 
highly coordinated events that include directional growth, septa alignment, and apoptosis (24). During 
embryonic life, a direct route between right and left atria is maintained, allowing a bypass of  the pulmo-
nary circulation, which is replaced by the placenta in fetal development. After birth, this communica-
tion normally ceases to exist due to occlusion of  the foramen ovale, caused by the increase of  pressure 
in the left ventricle, which leads to fusion of  the septum secundum to the foramen ovale; this allows the 
redirection of  blood to the pulmonary circulation. This communication can, however, remain open in 
15%–30% of  individuals as a benign condition named patent foramen ovale.
Analysis of  septum morphology showed an increased prevalence of  patent foramen ova-
les in Nkx2-5 heterozygous mice (71% in Nkx2-5183M/+ and 88% in Nkx2-5183P/+) when com-
pared with control mice (Nkx2-5C/+ or WT littermates) (Table 1). As previously described for 
Nkx2-5Δ/+ mice in a C57Bl/6J genetic background (24), we also detected marked enlarge-
ment of  patent foramen ovales in Nkx2-5 heterozygous mutants, with increased severity in 
Figure 3. Homozygous Nkx2-5 point mutant mice are embryonic lethal at 10.5 days after coitum. (A) At 10.5 days after coitum, Nkx2-5183M/183M and  
Nkx2-5183P/183P homozygous embryos show severe growth retardation, failure in cardiac looping, and hypoplastic hearts. Nkx2-5+/+ and heterozygous mice 
develop normally and are born at Mendelian ratios. Scale bars: 250 μm. (B and C) In situ analysis of embryos 9.5 days after coitum shows decreased levels of 
Nppa expression (direct target of NKX2-5) in homozygous embryos, being more severe in Nkx2-5183P/183P, and preserved expression of Mlc2v (a marker of cardi-
ac specification). At least 4 embryos were used for each genotype. Scale bars: 200 μm. Nppa,natriuretic peptide A; Mlc2v, myosin light chain isoform 2v.
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Nkx2-5183P/+ mice (Table 1). These large pat-
ent foramen ovales also showed altered mor-
phology. Furthermore, we detected a high 
percentage of  atrial septal defects (12%) in 
Nkx2-5183P/+ adult mutant mice, not previ-
ously seen in either Nkx2-5Δ/+, Nkx2-5C/+, 
or Nkx2-5183M/+ lines (24, 29), indicating 
increased severity of  septal abnormalities 
caused by proline mutation. The presence of  
atrial septal defects and increased prevalence of  patent foramen ovales are in line with expected patho-
logical outcomes observed in most patients showing mutations in NKX2-5 (30).
Nkx2-5 mutants display conduction defects, arrhythmia, and dysmorphic atrioventricular node. Defects in elec-
tric conduction are detected in most mouse models that show decreased Nkx2-5 activity, especially when 
this gene is deleted after neonatal stages (9–12). In these models, NKX2-5 activity was essential for proper 
development and homeostasis of  the sinoatrial and atrioventricular nodes, as previous full conditional dele-
tion of  Nkx2-5 led to arrhythmic episodes and heart failure (10). NKX2-5 has also been proven essential for 
transcriptional regulation of  several cardiac ion channels and receptors that play crucial roles in the gen-
eration and regulation of  the action potential in the heart. In humans, mutations in NKX2-5 are normally 
associated with electrical abnormalities and atrioventricular blocks (5, 29).
We observed electrocardiographic changes in some Nkx2-5183M/+ mice (2 of  6) under homeostatic, nonanes-
thetized conditions in several electric intervals, including increased PQ and QRS, and a small tendency for 
decreased ST intervals in both lines (Figure 5A). Analysis of  heterozygous Nkx2-5 mice using telemetry 
showed that Nkx2-5183M/+ mutants displayed occasional arrhythmic episodes with highly irregular PR inter-
vals, characteristic of  the presence of  ectopic sinoatrial foci leading to a wandering atrial pacemaker (4/5), 
associated with severe arrhythmia, which is typical of  second-degree atrioventricular block (Figure 5B and 
Supplemental Figure 4). Nkx2-5183P/+ displayed possible split QRS waves (3/8), indicative of  bundle branch 
heart block (Figure 5B and Supplemental Figure 4). Histological analysis of  the atrioventricular node region 
revealed reduction in node size 
(in Nkx2-5183M/+ mice, n = 4) 
or highly dysmorphic appear-
ance (in Nkx2-5183P/+ mice, n 
= 4) (Figure 5C). Expression 
of  direct targets of  NKX2-5 
(9, 29), such as ion channels 
Scn5a, Kcnh2, and Cacna1c that 
are essential for excitation-con-
traction coupling, were either 
unaltered or upregulated in 
Figure 4. Heterozygous Nkx2-5 mice develop 
severe right ventricular dysfunction associated 
with mild left ventricular changes. (A) Hearts 
from 15-week-old mice display right ventricular 
dysmorphism with a shift to the base, rounded 
apex, and severe right atrial dilation when com-
pared with Nkx2-5C/+ hearts. (B) Representative 
images from MRI show increased trabeculation 
or noncompaction of the left ventricle in Nkx2-
5183M/+ with even stronger penetrance in Nkx2-
5183P/+ hearts. (C) Mild left ventricular dysfunction 
associated with a high degree of right ventricular 
dysfunction. Control: n = 14; 183M: n = 10; 183P: n = 
8. *P < 0.05; ****P < 0.0001, unpaired t test equal 
variance 2 tailed. RA, right atrium; LA, left atrium; 
RV, right ventricle; LV, left ventricle; LV-EF, left 
ventricular ejection fraction; RV-EF, right ventricu-
lar ejection fraction.
Table 1. Prevalence of atrial septal defect (ASD) and patent foramen 
ovale (PFO) in heterozygous mutant Nkx2-5 hearts
Genotype ASD PFO Notes
wT 0/26 (0%) 10/26 (38%)
Nkx2-5C/+ 0/13 (0%) 5/13 (38%)
Nkx2-5183M/+ 0/21 (0%) 15/21 (71%) 1 with septal aneurysm
Nkx2-5183P/+ 2/17 (12%) 15/17 (88%) 6 with septal aneurysm
7insight.jci.org   https://doi.org/10.1172/jci.insight.88271
R E S E A R C H  A R T I C L E
mutant hearts, contrary to the expected downregulation (Supplemental Figure 5), suggesting that a com-
pensatory mechanism is in place to sustain the essential role of  excitation-contraction coupling in cardiac 
homeostasis, as previously observed for Nkx2-5Δ /+ mice (29).
Mutations in NKX2-5 do not affect overall protein levels. We have previously shown increased stability of  
NKX2-5 mutant proteins I-M and I-P in vitro, an event associated with decreased ubiquitin proteasome 
system–mediated degradation (22). In order to test if  this stability was maintained in vivo, we performed 
Western blots from adult hearts. Contrary to our previous in vitro observations (22), no significant chang-
es in NKX2-5 levels were detected between control or heterozygous mutant hearts (Figure 6), indicating 
that, at least in vivo, compensatory mechanisms balance protein production and degradation to maintain 
normal NKX2-5 overall levels in adult hearts. Whether mutant proteins retain WT transcriptional activa-
tion capacity in vivo remains to be determined.
Molecular analysis identifies altered pathways in Nkx2-5 mutant hearts. NKX2-5 protein persists in the heart 
throughout adult life, where the presence of  one mutant copy contributes to a wide variety of  cardiac 
Figure 5. Electrical disturbances detected in heterozygous Nkx2-5 mice. (A and B). Nonanesthetized and telemetric 
electrocardiogram analyses show a wide variability on QRS intervals of Nkx2-5183M/+, caused by frequent asymmetric atrial 
pacemaking activity (wandering atrial pacemaking). Similar widening of ST intervals were also detected in both mutants, 
with Nkx2-5183P/+ mice displaying frequent bundle blocks, widening of the QRS, and atrioventricular rhythm dissociation. In 
A, control: n = 12; 183M: n = 13, 183P: n = 8. In B, control: n = 5; 183M: n = 5, 183P: n = 8. (C) Abnormal atrioventricular node in 
heterozygous Nkx2-5 mutant mice, n = 3 of each genotype. **P < 0.01, unpaired t test equal variance 2 tailed.  
Scale bars: 200μm. P, P wave; QRS, QRS complex; ST, ST wave interval.
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phenotypes observed in patients (30). To dissect the long-term effects of  mutated pro-
teins, we performed microarray analyses of  Nkx2-5183M/+, Nkx2-5183P/+, and Nkx2-5183C/+ 
adult mutant hearts and the heterozygous null Nkx2-5Δ/+ model, which does not dis-
play the phenotype observed in the knock-in models (29). Global analysis of  these tran-
scriptional profiles showed that several known direct targets of  NKX2-5 in embryon-
ic development were highly compensated in adult heterozygote hearts, such that few 
genes (290 of  55,821) were differentially regulated between control and knock-in hearts 
(Figure 7A; 2-fold changes, P < 0.05). The large majority of  differentially expressed 
genes displayed modest 2- to 4-fold changes. In line with functional data, molec-
ular profiling demonstrated a gradient of  phenotype between 183M and 183P lines; 
Nkx2-5183P/+ hearts showed a more pronounced change in gene expression with propor-
tionally more repressed genes when compared with Nkx2-5183M/+ hearts. A stringent cut 
off  (P < 0.001) highlighted a subset of  genes likely associated with the cardiac phe-
notype in Nkx2-5183M/+ and Nkx2-5183P/+ adult hearts (Figure 7B). Within the genes sets coregulated by both 
Nkx2-5183M/+ and Nkx2-5183P/+ hearts (Supplemental Table 4), genes associated with processes of  cell adhesion 
(Scgb1c1), ion handling (Cacna2d1), proliferation/apoptosis (Ndrg4), cell signaling, organ morphogenesis, and 
homeostasis (Jmjd6, Six1, Scube, Myl1) were identified and further validated by qPCR (Figure 7C).
Interestingly, Nkx2-5Δ/+ heart profiling showed a large degree of  differential regulation compared with 
the point-mutants with 205 unique genes, while comparison of  Nkx2-5183M/+ and Nkx2-5183P/+ hearts revealed 
only 41 and 48 uniquely regulated genes, respectively. Despite the larger transcriptional changes observed in 
the Nkx2-5Δ/+ hearts, it is important to note that this line does not develop a phenotype consistent with the 
full presentation of  the human disease, underscoring the importance of  having the appropriate model for 
dissection of  mechanistic information (Figure 7B and Supplemental Table 4).
Comparative analysis of  all differentially regulated Nkx2-5183M/+ and Nkx2-5183P/+ targets with direct tar-
gets of  DamID-WT NKX2-5 protein in HL-1 cells shows a low degree of  correlation, with only 58 common 
targets (Supplemental Figure 6). These few common targets between HL-1 and our adult heart datasets are 
likely the direct targets of  NKX2-5 affected in the adult onset disease. These findings also suggest that most 
altered transcripts in the adult hearts (1,509 of  1,567) are secondary or off-targets of  NKX2-5 (35).
Mitochondrial dysfunction in Nkx2-5183P/+ cardiomyocytes. Using Mitocarta 2.0 (36), we identified an exten-
sive list of  nuclear mitochondrial–associated genes that were differentially expressed in Nkx2-5183P/+ hearts 
and postulated an involvement of  a primary respiratory defect in the phenotype of  point-mutations (Sup-
plemental Table 5). To follow up on this issue, we used the Seahorse technology (Agilent) to perform real-
time measurements of  energy utilization in living cells and observed a severe impairment of  mitochondrial 
function in neonatal cardiomyocytes derived from Nkx2-5183P/+ mutant hearts. While no significant changes 
in ATP production or proton leak were seen, a dramatic decrease was observed in basal and maximal respi-
ration, associated with a much lower baseline respiratory capacity (Figure 8). This suggests that respiration 
levels are close to maximum capacity under homeostatic conditions in Nkx2-5 mutant cardiomyocytes, 
likely not allowing for any respiratory reserve, if  required.
Nkx2-5 dysfunction leads to significant changes in Wnt signaling in adult hearts. Using ingenuity pathway anal-
ysis (IPA, Qiagen), we identified the process of  cardiogenesis as the major affected canonical pathway in 
Nkx2-5183P/+ hearts. The main altered genes in this process were the signaling pathways for BMP, TGFβ, 
and Wnt (Supplemental Figure 7). Wnt signaling is essential for heart development, patterning, and adult 
homeostasis and adaptation (37). Several differentially regulated transcripts were detected in our analysis 
(Table 2) and validated by qPCR in Nkx2-5183M/+ and Nkx2-5183P/+ adult hearts (Figure 9A) and neonatal car-
diomyocytes (Supplemental Figure 8). Transcripts for Fzd7, Tnik, Rock2, and Myl1 showed increased levels 
in Nkx2-5183M/+ and Nkx2-5183P/+ mutants compared with WT samples, while Hopx levels were downregulated 
in Nkx2-5183P/+ mice. Interestingly, Hopx has been recently shown to be an essential repressor of  the Wnt 
signaling that promotes cardiomyogenesis (38). Furthermore, Nkx2-5183P/+ neonate cardiomyocytes displayed 
sensitivity to increased concentrations of  Wnt3a, measured by increased accumulation of  β-catenin on the 
cell surface membrane when compared with WT cardiomyocytes (Figure 9B). Hypersensitivity to Wnt sig-
naling was further confirmed in transient transfection assays using the β-catenin–dependent Wnt reporter 
TopFlash. Using the ligand Wnt3a as a surrogate for canonical Wnt pathway activation, both Nkx2-5183P/+ 
and control neonatal cardiomyocytes were capable of  responding to increasing dosages of  Wnt (Figure 9C), 
although Nkx2-5183P/+ cardiomyocytes showed significantly higher activation of  TopFlash when compared 
Figure 6. NKX2-5 protein levels are not affected in 
heterozygous mouse lines. Western blot analysis of 
NKX2-5 protein levels using 15-week-old adult hearts. 
α-Tubulin was used as endogenous loading control. 
α-tub, α-tubulin; M, male; F, female.
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to control cardiomyocytes. Collectively, these results indicate enhanced sensitivity of  the response to Wnt 
signaling in Nkx2-5 mutant neonatal cardiomyocytes that could predispose them to the observed non-com-
paction phenotype in adult mutant hearts (Figure 4B and Supplemental Videos 1–3).
Besides its well-established role during cardiac development and specification, Wnt is essential in modulat-
ing cardiac response to injury by myocardial infarct (MI), hypertrophy and hypoxia/reperfusion (H/R) (37), and 
we observed an increase in Wnt3a levels in WT neonatal cardiomyocytes exposed to H/R or hearts subjected 
to MI (Figure 10A). Addition of Wnt3a also led to a substantial decrease in mitochondrial membrane potential 
(Figure 10B) and metabolism in neonatal cardiomyocytes (Supplemental Figure 9). In contrast, cardiomyocytes 
isolated from Nkx2-5183P/+ mice showed the opposite response in basal respiration and ATP production, and 
they were not capable of increasing respiratory capacity in response to Wnt3a (Figure 10C). This indicates 
that, in normal cardiomyocytes, upregulation of Wnt signaling limits cardiomyocyte respiratory activity, which 
decreases maximal respiratory capacity and increases reserve. Nkx2-5183P/+ cardiomyocytes, on the other hand, 
utilize their respiration to their maximum capacity at all times and are not capable of responding to the Wnt3a 
stimulus. These findings strongly implicate Wnt in Nkx2-5–mediated control of cardiomyocyte metabolism.
Figure 7. Transcriptome changes in adult heterozygous Nkx2-5 mouse hearts. (A) Global analysis shows subtle changes in the transcriptional profile 
between adult heterozygous mice and controls (P < 0.05). Color scheme reflects differential levels of expression, with lowest in gray, highest upregulation 
in deep red, and highest downregulation in deep blue. (B) Venn diagram comparing gene changes in both Nkx2-5Δ/+ and Nkx2-5183M/+, and Nkx2-5183P/+ in 
relation to Nkx2-5C/+ mice show few common genes among all models. The most significant changes are seen for Nkx2-5Δ /+, which does not phenocopy the 
human disease (P < 0.001). (C) qPCR validation of main differentially expressed targets shown as fold change normalized by expression of Hprt1. *P < 0.05; 
**P < 0.01; ***P < 0.001; ****P < 0.0001, 1-way ANOVA.
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Discussion
The accelerated discovery of  genetic mutations associated with human 
cardiac disease calls for the establishment of  precise models to study the 
relationship between genetic predisposition and cardiac dysfunction. Pre-
vious mouse models carrying homozygous or heterozygous Nkx2-5 gene 
deletions (9–12) displayed some but not all phenotypic characteristics of  
the human disease. Although phenotype discrepancies in these models 
could be interpreted as differences in experimental approaches and/or depth of  analyses, clinical manifes-
tations of  NKX2-5 dysfunction are likely caused by the interaction between WT and mutated proteins, as 
is the case in our patient cohort (22), and not by full lack of  a gene allele. Transcription factors operate in 
highly organized multimeric complexes with cofactors and general transcriptional machinery factors (35, 
39–42). Few examples exist in the literature where heterozygous deletion of  alleles reflects the human dis-
ease, as seen in Tbx5 and Holt-Oram Syndrome models (43).
In the case of  NKX2-5, most human cardiac defects are associated with heterozygous missense muta-
tions concentrated in the conserved homeodomain region, which cause impairment of  transcriptional 
activity mediated by decreased DNA binding (5). The knock-in models presented here are therefore ideal 
for the study of  the molecular pathways altered by long-term heterozygous mutant protein expression. 
In heterozygous configuration, they faithfully reproduce the major clinical characteristics of  congenital 
heart disease associated with mutations in this gene in patients, including atrial septal defects, conduction 
defects, and noncompacted myocardium. The embryonic lethality observed in homozygous I-M and I-P 
point mutants, similar to that observed in Nkx2-5 deletion (7, 8, 29), illustrates the strong disruption of  the 
cardiogenic program, even in the presence of  an otherwise intact NKX2-5 protein, underscoring the critical 
importance of  this residue in protein function.
Genetic background presents a further variable for consideration when building mouse models. The 
more penetrant cardiac phenotype of  an Nkx2-5 R189G knock-in compared with the clinical presentation 
seen in patients was strongly dependent on the genetic background used for the mouse studies, with highest 
severity associated with 129/SV and diluted in a mixed 129/SV;C57Bl6 background (44). In the present 
study, replacement of  the NKX2-5 isoleucine residue by methionine, the actual human mutation, produced 
a less severe phenotype than proline, a more severe but artificial change, which may also be affected by 
genetic background. In general, penetrance of  phenotype is more dependent on genetic modifiers in inbred 
mice than in humans (24, 45–47).
In spite of  the observed primary cardiac dysfunction of  the right side of  the heart at both morpho-
logical, contractile, and cellular respiratory levels, young adult Nkx2-5 knock-in mice still displayed a high 
degree of  physiological compensation that allowed for normal function, as illustrated by left ventricular 
ejection fraction. To our knowledge, right ventricular dysfunction in patients has so far not been associated 
with mutations in Nkx2-5, and it is a rather understudied phenomenon. A more detailed analysis of  right 
ventricular dysfunction should be performed in patients that carry NKX2-5 mutations, given the role Nkx2-
5 plays in outflow tract and pharyngeal arch formation, as well as the increased interest and importance 
of  the RV cardiac function in heart failure (32, 48, 49). Intriguingly, Nkx2-5183M/+ hearts were significantly 
smaller than both Nkx2-5183C/+ and Nkx2-5183P/+ hearts. It remains to be addressed whether this mutation has 
particular implications for determination of  heart size, an unknown association with Nkx2-5 gene function.
Our model also reproduced septal defects normally associated with NKX2-5 mutations in patients. Previ-
ous studies in adult Nkx2-5 mutant mice showed increases in atrial septal defects only in early neonatal stages 
(46, 47), raising the possibility that atrial septal defects could resolve with cardiac maturation after birth. 
Others reported septation defects that were much more severe than seen in patients (44). Our results are more 
consistent with the human condition, with atrial septal defects persisting in adult mice (Nkx2-5183P/+). Another 
common observation among Nkx2-5 knock-in models (50) is the presence of  electrophysiological abnormal-
Figure 8. Functional changes are associated with decreased mitochondrial respi-
ratory activity in neonatal cardiomyocytes. Nkx2-5183P/+ neonatal cardiomyocytes 
mitochondrial activity measured as basal respiration, ATP production, proton leak, 
maximal respiration, spare respiratory capacity, and nonmitochondrial respiration. 
(n = 5) *P < 0.05; **P < 0.01; ***P < 0.001, unpaired t test equal variance 2 tailed. 
OCR, oxygen consumption rate.
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ities. In addition to dysmorphic atrioventricular nodes, the Nkx2-5183M/+ line also displayed severe arrhythmic 
events characterized by wandering atrial pacemaker most likely caused by extra atrial pacemaking activity, 
perhaps associated with the severe right atrial dilation. In contrast, Nkx2-5183P/+ mice occasionally displayed 
complete atrioventricular block, associated with atrioventricular dissociation and possible bundle block.
Molecular analysis of  adult Nkx2-5 mutants showed an unexpectedly high degree of  compensation 
at the mRNA level, as proven by the small degree of  transcriptional changes in Nkx2-5 heterozygous 
hearts when compared with controls. Among the small proportion of  NKX2-5 direct targets affected in 
the knock-in lines (Table 2 and Supplemental Figure 7), several genes associated with the Wnt signaling 
pathway were of  particular interest, as Wnt signaling has been associated with a wide range of  devel-
opmental processes, including cellular specification, tissue patterning, and proliferation. During heart 
development, canonical and noncanonical Wnt signaling have temporally distinct roles, with an initial 
inductive role for cardiac specification followed by a repressive activity that promotes cardiomyocyte 
differentiation at later stages (51). Neonatal cardiomyocytes express several components of  the Wnt 
pathway (52) that are subsequently silenced in the adult heart. Although this pathway is reactivated in 
response to cardiac injury, repression is required for adaptive hypertrophy (53–55). Wnt3a signaling has 
been indirectly linked to Nkx2-5 through the regulation of  Scna5 channel, which is a direct target of  
NKX2-5 (52). NKX2-5 has been shown to directly repress β-catenin expression in ventricular myocytes 
(56). We did not detect changes in mRNA levels for β-catenin in our model. Contrary to experiments 
performed by Riazi et al., where Nkx2-5 was knocked down using an antisense strategy, our model is a 
heterozygous system where one WT copy and a mutant copy are present (56). In addition, large changes 
in β-catenin expression levels are not required to promote Wnt signaling, but rather changes in phosphor-
ylation status of  presynthesized protein associated with increase of  other pathway components, such as 
receptors and regulatory proteins, can exert a similar modulatory effect of  the Wnt pathway (37).
A role for Wnt signaling in Nkx2-5 mutant phenotypes was also supported by a significant 
decrease in Hopx transcripts in Nkx2-5 mutant neonatal cardiomyocytes (Figure 9A). Hopx has been 
implicated in cardiomyocyte specification through its repression of  Wnt signaling, failure of  which 
leads to noncompaction (38). A clear left ventricular noncompaction phenotype, with increased tra-
beculation and deep intratrabecular recesses, was especially evident in Nx2-5183P/+ hearts, similar to 
observations in patients (57).
The primary dysfunction of  mitochondrial metabolism found in this study (Figure 8, Supplemen-
tal Table 5, and Supplemental Figure 9) is consistent with the observed cardiac defects, including left 
Table 2. Differential expression of Wnt pathway genes in adult Nkx2-5 mutant hearts
Gene Name Gene Symbol Function Log Fc (M/P) P alue
Wnt family member 1 Wnt1 Ligand –0.68/NS 0.032/NS
Wnt family member 5a Wnt5a Ligand NS/1.16 NS/0.014
Wnt family member 8b Wnt8b Ligand –0.57/NS 0.038/NS
Wnt family member 9a Wnt9a Ligand NS/0.84 NS/0.009
Wnt family member 11 Wnt11 Ligand NS/0.66 NS/0.034
Wnt family member 16 Wnt16 Ligand 1.11/NS 0.050/NS
TRAF2 and NCK interacting 
kinase
Tnik Essential activator 0.59/0.83 0.034/0.006
Catenin beta interacting 
protein 1
Ctnnbip1 Negative regulator –0.35/–0.33 0.030/0.042
Family with sequence 
similarity 123, member B
Fam123b (Amer1) Negative regulator 0.89/1.22 0.041/0.005
Frizzled homolog 7 Fzd7 Receptor 0.48/0.52 0.001/0.001
Inversin Invs Negative regulator 0.67/0.68 0.042/0.039
Secreted frizzled-related 
sequence protein 5
Sfrp5 Inhibitor 1.42/1.92 0.028/0.005
Rho-associated coiled-coil 
containing protein kinase 2
Rock2 Cell polarity regulator (PCP) 0.43/0.71 0.045/0.003
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ventricular noncompaction (58, 59). Furthermore, Hopx also directly controls Bmp signaling through 
interaction with activated Smads, thereby influencing Wnt-Bmp pathway regulation of  cardiomyocyte 
specification (38). In fact, concomitant changes in Bmp-associated molecules were also seen in our 
model, including downregulation of  Bmp1/5/7/10 and Smad1 and upregulation of  Smads5/6 (Supple-
mental Figure 7 and Supplemental Table 6). A similar left ventricular noncompaction phenotype upon 
Figure 9. Wnt pathway genes are increased in Nkx2-5183M/+ and Nkx2-5183P/+ hearts. (A) 
qPCR targets associated with the Wnt pathway in adult hearts, shown as fold change 
over Hprt1. (B) Increased Wnt3a sensitivity reported by accumulation of β-catenin 
(b-cat, green) in the membrane of Nkx2-5183P/+ neonatal cardiomyocytes. (C) Dose-de-
pendent activation of β-catenin–dependent TopFlash reporter construct from control 
(WT) and Nkx2-5183P/+ mutant neonatal cardiomyocytes, expressed as fold activity of 
luciferase readings over unstimulated cells (no Wnt), normalized by Renilla expression. 
Wnt concentrations shown in μg/ml. n = 3. *P < 0.05; **P < 0.01; ***P < 0.001;  
****P < 0.0001, 1-way ANOVA (A) and unpaired t test equal variance 2 tailed (C). 
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Nkx2-5 deletion in adult ventricular cardiomyocytes was associated with upregulation of  Bmp10 (10). 
These results are consistent with the NKX2-5 control of  the Hopx-Wnt-Bmp axis. Thus, disturbances in 
the Wnt pathway may be at the core of  morphological changes observed in Nkx2-5 mutant mice.
Contrary to previous reports where NKX2-5 can bind and directly regulate expression of  β-catenin 
gene (Ctnnb1) (56), no changes were seen in expression of  Ctnnb1 in our model. Axin2, a direct target of  
Wnt/β-catenin activation, was also unchanged, reinforcing the existence of  a large degree of  transcrip-
tional compensation in adult hearts. We have, however, seen increased potentiality of  Nkx2-5183P/+ cardio-
myocytes to respond to a β-catenin element (TopFlash) once stimulated with Wnt3a, consistent with the 
upregulation of  several genes of  the pathway in Nkx2-5183P/+ hearts, including the overexpression of  the 
Wnt receptor Fzd7. At functional level, point-mutant Nkx2-5183P/+ cardiomyocytes show impaired mitochon-
drial respiratory capacity in homeostasis, similar to what is observed upon Wnt3a activation in stress for 
WT cardiomyocytes. Addition of  exogenous Wnt3a fails to reduce this response even further, implying 
that Nkx2-5183P/+ cardiomyocytes are insensitive to enhancement of  this pathway. Taken together, our data 
suggest that Nkx2-5183P/+ cardiomyocytes show increased Wnt signaling in homeostatic conditions, likely 
leading to the observed respiratory dysfunction. We predict that these events will lead to decreased cardiac 
capacity, energetic impairment, and worsening of  cardiac disease.
Figure 10. Wnt3a is upregulated in cardiac stress models and impairs mitochondrial respiration in Nkx2-5183P/+ neonatal cardiomyocytes. (A) qPCR 
shows an increase in Wnt3a expression in models of cardiac injury through hypoxia/reperfusion or myocardial infarction. Line represents control levels 
of Wnt3a in normoxic (hypoxia/reperfusion) and sham operated (myocardial infarction) mice. Results are shown as fold changes normalized by Hprt1 
expression. (B) Supplementation of Wnt3a to primary neonatal cardiomyocytes leads to decreased mitochondrial membrane potential (n = 6), measured 
by JC-1 membrane permeant dye staining. (C) WT cardiomyocytes show better mitochondrial performance in all measured parameters when compared with 
Nkx2-5183P/+ (basal respiration, ATP production, proton leak, maximum respiration, and spare respiration). Upon Wnt3a stimulation, WT cardiomyocytes 
reduce energy consumption and increase spare respiratory capacity, while Nkx2-5183P/+ cardiomyocytes retain similar low levels of mytochondrial activity 
and dramatically increase nonmitochondrial respiration. n = 6. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001, unpaired t test equal variance 2 tailed. 
MI, myocardial infarction; H/R, hypoxia/reperfusion; OCR, oxygen consumption rate in picomols per minute.
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One of  the biggest challenges for the understanding of  complex congenital heart disease lies on the 
large number of  genes involved and the high phenotypic variability observed (60). The emergence of  
proper disease mammalian models is therefore paramount in the dissection of  processes and pathways 
associated with adult congenital heart disease, such as the ones described here for Nkx2-5. These knock-
in models will be invaluable in enhancing the analysis of  environmental events and modifiers of  cardiac 
function (e.g., obesity, high blood pressure) in a context of  genetic predisposition, an increasing conse-
quence of  high survival rates associated with clinical interventions in pediatric cardiology.
Methods
Mouse lines generation. Nkx2-5C/+, Nkx2-5183M/+, and Nkx2-5183P/+ mice were generated by the Gene Recom-
bineering and Embryonic Stem Cell Targeting Facilities at the Australian Regenerative Medicine Institute, 
Monash University. Neomycin cassette deleted lines (Nkx2-5CΔ, Nkx2-5MΔ and Nkx2-5PΔ) were obtained 
by crossing with the CMV-Cre deleter line (61). Nkx2-5f/+ and Nkx2-5Δ/+ are described elsewhere (29). All 
mice were kept on a C57BL6/J background, housed at Monash Animal Services - Monash University or at 
the Rodent Animal Facility - the Jackson Laboratory.
Histology, immunofluorescence, and acetylcholinesterase (AchE) staining. Hearts were fixed in 4% 
paraformaldehyde at 4oC for 12 hours and further processed for paraffin embedding and histological 
analysis. Sections were analyzed using Masson’s Trichrome staining. For myocyte area measurements, 
transverse sections were stained with Wheat Germ Agglutinin-AF 488 conjugate (Invitrogen) and further 
quantified with the FIJI software, using 3 replicates for each genotype. For the AchE analysis, hearts 
were fixed for 10 minutes in 4% paraformaldehype and processed for cryosectioning in optimal cutting 
temperature (OCT) compound. Staining was performed as previously described (62). All images were 
obtained using Olympus DotSlide.
MRI, microCT, and electrocardiogram. Adult mice were anesthetized with isoflurane for noninvasive 
imaging in a prone position before surgical procedure. Imaging was performed in spontaneously breathing 
animals on a 9.4 Tesla MRI scanner (Agilent) to assess left and right ventricular chamber dimensions using 
cardiac and respiration gated cine sequences. Breathing was monitored to avoid measurement distortions 
during breathing cycle. Measurements of  cardiac function were performed using the Segment software (63).
For microCT analysis, 18.5 days after coitum, embryos were dissected and exsanguinated through 
the severed umbilicus for 10 minutes at 37 °C in Ca2+/Mg2+-free PBS containing 0.02% heparin fol-
lowed by immersion in 60 mM KCl. Embryos were fixed overnight at 4°C in 4% paraformaldehyde 
and stored at 4 °C in PBS/0.02% sodium azide. To stabilize volume during imaging, embryos were 
incubated in hydrogel solution (4% paraformaldehyde [Electron Microscopy Sciences], 4% acrylamide 
[Bio-Rad], 0.05% bis-acrylamide [Bio-Rad], 0.25% VA044 Initiator [Wako Chemicals], 0.05% sapo-
nin [Sigma-Aldrich] in PBS) at 4 °C for 3 days. After incubation, air in the tube was replaced with 
nitrogen gas and the gel polymerized at 37 °C for 3 hours. Samples were manually separated from the 
encasing gel and stained in Lugol’s solution (Sigma-Aldrich) for 24 hours. The iodine-stained embryo 
was embedded in 1% agarose (Lonza) in an 11-mm Ultra-Clear centrifuge tube (Beckman Coulter) for 
scanning. Datasets were acquired using a Skyscan 1172 high-resolution microCT scanner (Bruker), at 
100 kVp and 100 μA, 0.5-mm aluminium filter, step size of  0.3°, averaging of  9, and pixel size of  13.4 
μm. Data were reconstructed using Bruker NRecon software with misalignment compensation and 
ring artifact corrections as needed.
Electrocardiograms (ECG) were obtained on nonanesthetized mice using the ECGenie system (Mouse 
Specifics) and intervals calculated using EzCG software (Mouse Specifics).For telemetry analysis, 30-week-
old male mice from each group were implanted with radiotelemetry probes into the left carotid artery 
(TA11PA-C10, Data Science International) under anesthesia with isoflurane. Mice were allowed to recover 
for 1 week, followed by 24-hour monitoring of  blood pressure and ECG.
Atrial septal morphological analysis. To detect patent foramen ovale and atrial septal defect, adult mouse 
hearts were dissected and visually inspected under a stereoscope. Briefly, the left atrial appendage was 
removed to expose the atrial septum and record blood flow induced by pressurizing the right atrium, as 
previously described (24). Septa with normal morphology but a patent flap valve were scored as patent fora-
men ovales. Direct overlap of  the ostium secundum and the foramen ovale was scored as an atrial septal 
defect (24). Excess or hyperelastic tissue over the foramen ovale, capable of  protruding significantly when 
pressurising the right atrium, was scored as atrial aneurysm.
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Cell culture. The mouse atrial cardiomyocyte HL-1 cell line was grown in Claycomb media (Sigma-Al-
drich) supplemented with 10% FBS (Gibco) and norepinephrine (Sigma-Aldrich), maintained in a humid-
ified 5% CO2 incubator at 37
oC. Cell lines were electroporated (NEON system, Invitrogen) following man-
ufacturer’s instructions.
Imaging and photoactivatable f lourescence correlation spectroscopy (paFCS) measurements. Nkx2-5paG-
FP constructs were generated with In-Fusion HD Cloning kit (Clontech) with PCR fragments from 
Nkx2-5 WT/mutant expression plasmids (22) fused to a photoactivatable form of  GFP (paGFP) as 
previously described for Oct4 (primers described in Supplemental Table 5; ref. 28). HL-1 cells were 
electroporated as described above using Neon Transfection System (Invitrogen). Cells were cultured 
in Lab-Tek chambers (Nunc) with 0.1% gelatin and imaged 72 hours after elecroporation. Zeiss LSM 
780 laser scanning confocal microscope/avalanche photodiodes of  the Confocor 3 module (Zeiss, 
Jena) was used and analyzed as previously described (28). Cell nuclei were identified by the expression 
of  H2B-RFP. paFCS measurements of  WT Nkx2-5 and I-M, I-P mutants transiently transfected into 
HL-1 showed two protein movement components, a faster Brownian component (associated with free, 
unbound NKX2-5) and a slower (in the order of  milliseconds) highly anomalous component, repre-
senting the bound/target searching component).
Neonatal cardiomyocyte preparation and mitochondrial activity. Neonatal cardiomyocytes (postnatal day 
2) were prepared as previously described (64). Cells (1 × 105) were added to each well in a fibronectin 
coated 96-well CM plate (Seahorse). After 24 hours, regular media was replaced with fresh media con-
taining 2% FBS and Wnt3a (0.6 μg/ml) for 48 hours. Mitochondrial activity (65) was assessed using the 
Seahorse system (Seahorse Bioscience). Final concentrations used for injection were 1 μM Oligomycin, 
1.75 μM FCCP, and 1μM Antimycin-A.
Transfections and Wnt activity measurements. Neonatal cardiomyocytes were transfected using Viromer 
Yellow (Lipocalix) 48 hours after isolation using TopFlash Wnt reporter plasmids (66). Recombinant 
Wnt3a (R&D Systems) was added 5 hours after transfection. Cells were lysed in 1× RLB (Biotium) 24 
hours later, and luciferase activity was measured using Firefly & Renilla Luciferase Assay Kit (Biotium) 
using a Fluostar Optima (BMG Labtech) plate reader.
Microarray, bioinformatics analysis, and qPCR validation. Triplicate samples from 15-week adult male 
hearts were processed for total RNA extraction using the mirVana kit (Invitrogen) and DNAse digest-
ed. Samples were further processed at the Medical Genomics Facility and run on Agilent SurePrint 
G3 mouse gene expression arrays (single color). Raw single-channel signals provided by the Agilent 
Feature Extraction image analysis software was used for data analysis and deposited at GEO under 
the access number GSE85902. Log2 transformation and normalization was done in R scripts using 
public Bioconductor packages (67). Differential analysis was performed using the Bioconductor Lim-
ma package (68), which fits a linear model of  gene expression. Differentially expressed genes (P < 
0.01) were retained for fold-change calculation. For transcriptional analysis in embryos, total RNA 
was isolated from at least three dissected hearts 9.5-day after coitum using RNAqueous4PCR micro 
kit (Invitrogen), and DNAse digested. cDNA synthesis was performed using the Superscript VILO 
kit (Invitrogen) following manufacturer’s instructions. qPCR reactions were performed using SYBR 
green master mix (Roche Diagnostics) and analyzed using the LightCycler480 (Roche Diagnostics). 
At least two individual experiments in triplicate were performed, using the hypoxanthine phosphoribo-
syltransferase 1 gene (Hprt1) as a normalizer. Primers/probes are described in Supplemental Table 2. 
In situ hybridization was performed as described (69). Probes were generated by RT-PCR and cloned 
into pGEMTeasy (Promega). To obtain antisense transcripts, reactions were performed using T7 RNA 
Polymerase (Roche Diagnostics). Antibodies are listed in Supplemental Table 7. Venn diagrams were 
generated using BioVenn (70).
Statistics. All results are reported as the mean ± SEM. Statistical analysis was performed using unpaired, 
2-tailed Student’s t test or ANOVA using Graphpad Prism 6 (GraphPad Software Inc.). P < 0.05 was con-
sidered significant unless otherwise stated. P values are presented in the figure legends.
Study Approval. The investigation conforms to the Guide for the Care and Use of  Laboratory Ani-
mals published by the US National Institutes of  Health (NIH Publication No. 85–23, revised 1996) 
and with requirements under the ethics application MARP-2011-175 (Monash University) and ACUC-
16011 (The Jackson Laboratory).
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